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Abstract
High-frequency, low-magnitude vibration enhances bone formation ostensibly by mimicking normal postural muscle
activity. We tested this hypothesis by examining whether daily exposure to low-magnitude vibration (VIB) would maintain
bone in a muscle disuse model with botulinum toxin type A (BTX). Female 16–18 wk old BALB/c mice (N=36) were assigned
to BTX-VIB, BTX-SHAM, VIB, or SHAM. BTX mice were injected with BTX (20 mL; 1 U/100 g body mass) into the left hindlimb
posterior musculature. All mice were anaesthetized for 20 min/d, 5 d/wk, for 3 wk, and the left leg mounted to a holder.
Through the holder, VIB mice received 45 Hz, 60.6 g sinusoidal acceleration without weight bearing. SHAM mice received
no vibration. At baseline and 3 wk, muscle cross-sectional area (MCSA) and tibial bone properties (epiphysis, metaphysis
and diaphysis) were assessed by in vivo micro-CT. Bone volume fraction in the metaphysis decreased 1269% and 766% in
BTX-VIB and BTX-SHAM, but increased in the VIB and SHAM. There were no differences in dynamic histomorphometry
outcomes between BTX-VIB and BTX nor between VIB and SHAM. Thus, vibration did not prevent bone loss induced by
a rapid decline in muscle activity nor produce an anabolic effect in normal mice. The daily loading duration was shorter than
would be expected from postural muscle activity, and may have been insufficient to prevent bone loss. Based on the
approach used in this study, vibration does not prevent bone loss in the absence of muscle activity induced by BTX.
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Introduction
High strain magnitudes (.1000 me) and strain rates are well
documented characteristics of an osteogenic mechanical stimulus
[1,2]. However, evidence suggests that lower magnitude vibration
(,1 g acceleration) applied at higher frequencies (.10 Hz) also
promotes osteogenesis [3,4]. The application of low-magnitude
vibratory stimuli to prevent bone loss was initiated, in part, due to
the high prevalence of low strain magnitude events observed in
bone during daily activities [5]. Further, there is an inverse, non-
linear relation between the incidence of events and magnitude of
strain that maintain bone mass, suggesting that loading regimes
performed at a sufficiently large number of cycles per day, at lower
strain magnitudes may elicit an osteogenic response [6]. These
findings suggested that low-magnitude, rather than high-magni-
tude, strain events can drive osteogenesis and perhaps prevent
bone loss.
Many studies have since demonstrated that low-magnitude
vibration is osteogenic in animals [3,7,8,9,10,11] and in humans
who comply with the vibration training protocol (1–2 sessions x
10 minutes/day) [12,13]. However, other studies applying similar
protocols in animals and humans failed to demonstrate a positive
effect of low-magnitude vibration [14,15,16]. These conflicting
results indicate that the mechanisms and parameters (i.e.,
frequency, strain and, acceleration amplitude) by which high-
frequency, low-magnitude vibration drives bone formation are
poorly understood. A better understanding of the mechanism
underlying bone’s ability to adapt to low-magnitude mechanical
signals is needed to design effective interventions to prevent or
mitigate bone loss.
One potential source of endogenous high-frequency, low-
magnitude strains observed in bone may be muscle activity
[3,17]. Muscles are known to play an important role in trans-
mitting mechanical stimuli to bone [18,19], and postural muscles
emit high-frequency vibrations (10–50 Hz) when activated [20].
Further, the frequency content in the 30–50 Hz range, associated
with the firing rates of fast-twitch muscle fibres, decline with age
[20]. This decline, related to the preferential decrease of fast-
twitch muscle fibres with age, may contribute to age-related bone
loss. Based on these collective findings, Rubin and colleagues
[5,6,20] postulated that bone mass may be maintained as a result
of high-frequency, low-magnitude strains produced by postural
muscle activity, and that exogenous high-frequency, low-magni-
tude vibration may promote bone adaptation by mimicking
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proposition that bone is maintained by postural muscle activity
has not been examined.
While most studies have delivered vibration to the lower limbs
via whole body vibration (WBV), recent findings suggest that
weight-bearing and muscle activity may not be required to induce
an osteogenic response to low-magnitude vibration [21,22,23].
Specifically, bone formation rates increased when vibration was
delivered to a single hindlimb while a mouse was anaesthetized,
regardless of whether the mouse was exposed to normal
ambulation [22] or disuse as a result of hindlimb unloading [21]
for the rest of the day.
Another means of trigerring disuse is by inhibiting muscle
activation with injection of botulinum toxin type A (BTX). We,
and others, have previously demonstrated that BTX-induced
muscle and bone loss occurs within one week post-injection [24],
and is maintained for at least four weeks post-injection [25,26].
Further, BTX-induced bone loss appears to occur primarily as
a result of muscle atrophy [27] and has minimal effects on gait
[28] and weight-bearing ability in the injected limb [29].
Therefore, we hypothesized that daily exposure to high-
frequency, low-magnitude vibration would maintain bone struc-
ture despite muscle disuse in mice. Further, we wanted to confirm
the result that vibration could increase bone formation in healthy,
normal mice. To test this hypothesis, we triggered muscle disuse in
skeletally mature mice by injection with BTX. We applied daily
exposure to vibration without weight-bearing, using an osteogenic
protocol designed by Garman et al. [21,22].
Materials and Methods
Animal Model and Experimental Design
Thisexperimentwasconductedintwoparts.Inbothpartsfemale,
16–18 week old, skeletally mature BALB/cAnNCrl (BALB) mice
[30,31] were obtained from Charles River Laboratories (Saint-
Constant, Quebec, Canada). For Experiment 1, 27 mice were
assigned to one of the following groups: high-frequency, low-
magnitudevibration+injectionwithbotulinumtoxintypeA(BTX-
VIB, n=9), BTX-SHAM (n=8), or SHAM (n=8). For Experi-
ment 2, 11 mice were assigned to high-frequency, low-magnitude
vibration (VIB, n=8) or SHAM (n=3). Group assignment was
performedtoensureconsistentmeanbodymassbetweenthegroups.
The animals for each experiment were obtained at different dates,
andthusthereweresmalldifferencesinbaselinebodymassbetween
experiments. Additional mice (n=2) were sacrificed prior to
commencing Experiment 1 for strain measurements. BTX mice
were injected with 20 mL of BTX Type A (BOTOX, Allergan Inc.,
1 U/100 g) into the left posterior lower limb musculature (single
injection targeting gastrocnemius, plantaris, and soleus) immedi-
ately following baseline measurements. Beginning 4 days after
baseline measurements, VIB mice received a high-frequency
(45 Hz), low-magnitude mechanical stimulus to the left, treated,
tibia. The stimulus was sinusoidal and delivered with a peak
accelerationof60.6 g.Theright,untreated,legwasnotloadedand
remainedonthebed.SHAMmicewerehandledandattachedtothe
oscillatory device, but the vibration stimulus was not applied. The
vibrationandshamprocedureswereconductedwiththemiceunder
isoflurane anaesthesia for 20 minutes/day, 5 days/week for
3 weeks. The timeline of the experimental protocol is outlined in
Figure 1.
All animals were housed in groups and provided standard rodent
chowandwateradlibitum.FollowingBTXinjection,BTXmicewere
providedwithfoodandNapaNectar(SELabGroup,Napa,CA)on
the cage bottom to ease access to food for one week post-injection.
Otherwise, normal cage activity with normal weight-bearing was
permitted. Body mass was monitored after each vibration session
and reported weekly. Micro-computed tomography (micro-CT)
scanswereperformedatbaselineandpriortosacrificeonday 21.To
assess dynamic indices of bone formation, in Experiment 1, mice
wereinjectedwithcalceingreen(1 mg/100 g;IP)ondays 8and19.
InExperiment2,micewereinjectedwithcalceingreenonday 8and
oxytetracycline (2.5 mg/kg; IP) on day 19. Mice were sacrificed
overtwodays(days 21and22),toallowtimeforscanningandtissue
processing, via cervical dislocation while under anaesthesia. All
procedures were approved by the Health Sciences Animal Care
Committee at the University of Calgary.
Application of Low-Magnitude Mechanical Stimulus
Application of the high-frequency, low-magnitude mechanical
stimulus was performed in the absence of weight-bearing. The
protocol was designed to replicate that described by Garman et al.
[21,22], as they detected positive effects of vibration without
weight-bearing in the proximal tibia epiphysis with micro-CT.
The apparatus to deliver the displacements included a vibration
shaker (V203, Ling Dynamic Systems, Royston, England) driven
by an amplified sinusoidal tone generator signal (Power Amplifier
Type 2706, Bru ¨el & Kjær, Nærum, Denmark; NCH Tone
Generator v2.12, Canberra, Australia). The mouse was positioned
in a bed on its back, and the distal portion of the left leg fixed to
a holder with a strap, with the tibio-femoral angle at approxi-
mately 120u. The vibration was applied along the longitudinal axis
of the tibia (Figure 2).
Acceleration was measured throughout the vibration protocol
using a uniaxial accelerometer (EGAX-10, Entran Devices, range
610 g, Fairfield, NJ, USA) fixed to the holder between the leg and
shaker. Acceleration signals were amplified (2310A Signal
Conditioning Amplifier, Measurements Group Inc.), sampled at
1000 Hz (DATAQ Instruments Model DI-205, Akron, OH), and
displayed on a computer screen (WinDaq Acquisition DI 720,
DATAQ Instruments, Akron, OH) for continuous monitoring.
Strain Quantification
Strain measurements were performed in two mice immediately
after sacrifice, prior to commencing the study. The anterior
surface of the proximal tibia diaphysis was minimally cleaned of
soft tissue, and a single element strain gauge (FLK-1–11, Tokyo
Sokki Kenkyujo Co., Tokyo, Japan) was fixed to the anterior tibia
using cyanoacrylate strain gauge adhesive (CN adhesive, Tokyo
Sokki Kenkyujo Co., Tokyo, Japan). The longitudinal axis of the
strain gauge was aligned with the longitudinal axis of the tibia.
Strains were amplified (2310A Signal Conditioning Amplifier,
Measurements Group Inc., Raleigh, NC, USA), and sampled at
1000 or 2000 Hz (WinDaq Acquisition DI 720, DATAQ
Instruments Model DI-205, DATAQ Instruments, Akron, OH,
USA) during 3 trials with 45 Hz, 60.6 g sinusoid, and with no
signal applied. Using MATLAB (R2008a, Natick, MA, USA),
strain signals were filtered with a 200 Hz 2
nd order Butterworth
low-pass filter (using the function ‘filtfilt’) [5,21]. Peak-to-peak
strains and frequency content of the resulting signal with the Fast
Fourier Transform function (FFT).
In vivo Micro-CT
An in vivo micro-CT scanner (vivaCT 40, Scanco Medical,
Bru ¨ttisellen, Switzerland) quantified muscle cross-sectional area
(MCSA) and bone outcomes. Mice were anaesthetized with
isoflurane and maintained on anaesthetic gases for the duration of
the scan. The hindlimbs were positioned and scanned in parallel
with a custom fixture to obtain images of both limbs [27]. Scans
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replicate the regions examined by Garman et al. [21], as well as
the proximal tibia diaphysis. The procedure described briefly
below follows methods used previously for scans obtained at
baseline and 3 weeks [27,29].
Muscle Outcomes
In-vivo Muscle Measurements. MCSA (mm
2) was mea-
sured in the diaphyseal region of each lower hindlimb using in vivo
micro-CT. The volume scanned was a 2.65 mm slab encompass-
ing the maximal MCSA, as determined in pilot experiments,
beginning 2.2 mm distal to the tibial growth plate. The scanning
parameters used were 45 kVP, 133 mA, 620 ms integration time,
250 projections/180u resulting in a 50 mm isotropic voxel size and
a total scan time of 6 minutes [32].
Image Processing. For each hindlimb a 0.8 mm slab was
extracted from the gray-scale images and Gaussian filtered
(s=1.2, support =2). All micro-CT image intensities are
expressed as a fixed fraction of the maximal gray-scale value
(1000). Three threshold values were used to produce segmented
images of the entire leg (2.4% of maximal gray value), muscle
region excluding the subcutaneous fat (10.6% of maximal gray
value), and bone (15% of maximal gray value).
Ex-vivo Muscle Measurements. Upon sacrifice, the poste-
rior compartment muscles (gastrocnemius and soleus) and tibialis
anterior were dissected, and wet muscle mass (mg) was measured.
Bone Outcomes
Each proximal tibial micro-CT measurement examined
a 5.3 mm thick slab, corresponding to 424 slices encompassing
the proximal tibia epiphysis and metaphysis. The scanning
parameters used were 55 kVP, 133 mA, 200 ms integration time,
2048 samples and 1000 projections/180u, resulting in a 12.5 mm
isotropic voxel size and a total scan time of 20 minutes. The
proximal tibia diaphysis measurement was obtained during the
muscle scan.
Image Processing. Volumes extracted from each limb
included the proximal tibia epiphysis (encompassing the entire
epiphysis), the proximal tibia metaphysis (a 1 mm slab extending
distally from the growth plate), and the proximal tibia diaphysis (a
0.8 mm slab beginning 2.2 mm distal to the tibial growth plate).
Hand-drawn contours were used to isolate the metaphyseal region
of interest; trabecular and cortical compartments were segmented
using an automated method [33]. After segmentation, the resulting
gray-scale images were Gaussian filtered (s=1.2, support =2). A
global threshold was applied (27.5% of maximal gray-scale value
for diaphyseal volumes, 30% of maximal gray-scale value for
Figure 1. Diagram of the experimental protocol.
doi:10.1371/journal.pone.0036486.g001
Figure 2. Apparatus used to apply high-frequency, low-magnitude vibration to the lower limb of mouse, along the longitudinal
axis of the tibia. A strap (not shown) held the hindlimb in place.
doi:10.1371/journal.pone.0036486.g002
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which morphological analyses were performed.
Morphological Analysis of Micro-CT Scans. Bone micro-
architecture was assessed with direct 3D methods (Image
Processing Language v. 5.07b; Scanco) [34]. Morphological
measurements in the trabecular region of the epiphysis and
metaphysis included total bone volume (BV, mm
3), trabecular
bone volume fraction (BV/TV, %), trabecular thickness (Tb.Th,
mm), trabecular separation (Tb.Sp, mm), and trabecular number
(Tb.N, mm
21). In addition, several non-metric parameters were
assessed including structural model index (SMI) [35], connectivity
density (ConnD, mm
23) [36], and degree of anisotropy (DA). In
the cortical region of the metaphysis and diaphysis, cortical area
(Ct.Ar, mm
2) was calculated, excluding porosity, as well as total
area within the periosteal envelope (Tt.Ar, mm
2), and area within
the marrow cavity (Ma.Ar, mm
2).
Dynamic Histomorphometry. After sacrifice, the tibiae
were dissected, cleared of soft tissue, and fixed in 70% ETOH.
Subsequently, the left, treated, tibiae from all mice were
dehydrated and embedded, undecalcified, in poly methyl meta-
crylate (PMMA), thick sectioned in the axial plane using a diamond
band saw (EXAKT, Norderstedt, Germany), and ground to
100 mm thickness. Sections were visualized using epifluorescence
with near-infrared filters on a Axiovert system (Zeiss, Jena,
Germany). Within the trabecular bone region, single-labeled
surface (sLS), double-labeled surface (dLS), and bone surface (BS)
were measured with Image-Pro AMS (v5.1.2.59, Media Cyber-
netics, Bethesda, MD, USA). Interlabel thickness (Ir.L.Th, mm)
was also measured with Bioquant Osteo (Bioquant Image Analysis
Corporation, Nashville TN, USA) or Osteomeasure (Osteo-
metrics, Decatur GA, USA). From these measures, percent
single-labeled surface (%sLS), percent double-labeled surface
(%dLS), mineralizing surface (MS = (dLS + sLS/2)/BS, %),
mineral apposition rate (MAR = Ir.L.Th/Ir.L.T, mm/d, with
Ir.L.T = interlabel period), and bone formation rate (BFR =
MAR * MS/BS, mm
3/mm
2/y) were calculated [37].
Statistical Analysis
Changes in whole body mass were examined with a two-way
analysis of variance (ANOVA) with Group (BTX-VIB, BTX-
SHAM, VIB, SHAM) as a between-subject factor and Time as
a within-subject factor. Mean change from baseline was used as
the outcome for all micro-CT variables. To examine changes in
micro-CT variables and muscle mass, two-way ANOVAs were
performed with Group (BTX-VIB, BTX-SHAM, VIB, SHAM) as
a between-subject factor and Leg (treated, untreated) as a within-
subject factor. Simple effect testing with a Bonferroni correction
was used to interpret significant interactions. Differences in bone
histomorphometry were examined with a one-way ANOVA with
Group as a between-subject factor and Tukey’s post-hoc test. IBM
SPSS Statistics version 19.0 (SPSS Inc., Chicago) was used for all
statistical analyses. Values are expressed as mean 6 SD in tables
and mean 6 SE in the figures for clarity. The significance level
was set at p,0.05. Effect size is reported as the partial eta-squared
(g
2) for the interaction effects as well as simple effects and post-hoc
tests to estimate the proportion of variability associated with the
comparison of interest [38].
Results
Strain Measurement
A sinusoidal, 45 Hz vibration signal with 60.6 g acceleration
induced peak-to-peak strains of 5.860.3 me with a mean of zero
on the proximal tibia recorded in several trials on two mice
(Figure 3A). There was a slight lag or phase shift between recorded
acceleration and strain (Figure 3B). The phase shift is consistent
with the soft tissue compliance effects between the vibration shaker
and the strain measurement location. The predominant frequency
peak in the spectrum of the strain recording with 60.6 g
acceleration input was 45 Hz. In contrast, there was no discern-
able strain signal when vibration was not applied.
Body Mass and Muscle Outcomes
Body mass decreased in both BTX groups after baseline (Group
x Time interaction, p,0.001, partial g
2=0.63). At day 21, body
mass remained 4.461.2% lower than baseline in the BTX-VIB
group (p,0.001, parital g
2=0.97) and 6.262.4% lower than
baseline in the BTX-SHAM group (p,0.001, parital g
2=0.96).
Body mass did not change significantly in the SHAM but
increased 3.760.8% (p=0.003, partial g
2=0.97) in the VIB
groups.
There was a significant Group x Leg interaction for MCSA
(p,0.001, partial g
2=0.94). Within-group change in MCSA was
not significantly different between the BTX-VIB and BTX-SHAM
groups (Table 1, p.0.05, partial g
2=0.07). However, MCSA
decreased in the treated leg of the BTX-VIB group by
47.663.4%, and in the BTX-SHAM group by 46.163.5%, and
these declines were significantly greater than the SHAM group
(p,0.001, partial g
2=0.93 and p,0.001, partial g
2=0.91,
respectively). While there was a trend towards a greater increase
in MCSA in the treated leg of the VIB than SHAM group
(p=0.16, partial g
2=0.18), and a significantly greater increase in
the untreated leg of the VIB than SHAM groups (p=0.004,
partial g
2=0.27), this was likely associated with the slightly lower
baseline MCSA in the mice used in Experiment 2. There was also
a significant decrease in MCSA in the untreated leg of the BTX-
VIB group compared with the SHAM group (p=0.02, partial
g
2=0.47).
Similarly, gastrocnemius, soleus, and tibialis anterior muscle
masses were significantly lower in the treated leg of the BTX-VIB
and BTX-SHAM groups compared with the SHAM and VIB
groups (significant interactions, p,0.001 for all significant
comparisons, Table 2). However, tibialis anterior mass was
significantly higher in the BTX-VIB than BTX group (p=0.04,
partial g
2=0.30). Gastrocnemius mass was also significantly lower
in the untreated leg of BTX-VIB and BTX-SHAM than the
SHAM group (p,0.001 and p=0.005, respectively, partial
g
2=0.97). There were no differences in muscle mass between
the VIB and SHAM groups.
Bone Outcomes
Bone micro-architecture declined in the treated leg of both
BTX groups. In the proximal tibia metaphysis, BV/TV decreased
11.868.5% in the treated leg of the BTX-VIB group and
7.366.4% in the BTX-SHAM group, but increased 25.863.9%
in the treated leg of the SHAM group and 16.464.9% in the VIB
group. These within-group decreases in the BTX groups were
significantly different from the SHAM (p,0.001, partial g
2=0.51)
and VIB groups (p=0.01, partial g
2=0.04 compared with BTX-
VIB and p=0.02, partial g
2=0.02 compared with BTX-SHAM,
Figure 4A). Similarly, the within-group decreases in metaphyseal
Tb.Th in the treated leg of both BTX groups differed from the
SHAM and VIB groups (p,0.003, partial g
2 .0.51 for all
significant comparisons, Figure 4B). We observed similar trends
between groups in the proximal tibia epiphysis (Figure 5). The
within-group decreases in BV/TV in the treated leg of the BTX-
VIB group (1761.7%) and BTX-SHAM group (1962.4%)
differed significantly from the SHAM (p,0.001, partial
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2=0.33) and VIB groups (p=0.02, g
2=0.41 compared with
BTX-VIB and p=0.002, partial g
2=0.39 compared with BTX-
SHAM, Figure 5A). Similarly, the within-group decreases in
epiphyseal Tb.Th (p,0.001, partial g
2=0.38, Figure 5B) and DA
(p,0.001, partial g
2=0.39, Figure 5F) in the treated leg of the
BTX groups were significantly different from the SHAM group.
Figure 3. Strain (A) and acceleration (B) vs. time for a 0.2 s portion of one trial. The strain gauge was fixed to the anterior surface of the
proximal tibia. The accelerometer was fixed to the leg holder.
doi:10.1371/journal.pone.0036486.g003
Table 1. Effect of treatment (BTX-VIB, BTX-SHAM, VIB, SHAM)
on muscle cross-sectional area (mm
2).
Leg Treatment Baseline Day 21
Treated BTX-VIB 72.863.7 38.263.9
a,b
BTX-SHAM 72.762.4 39.263.9
a,b
VIB 68.364.5 73.262.6
SHAM 73.065.3 73.564.2
Untreated BTX-VIB 72.064.5 67.864.0
c,d
BTX-SHAM 71.762.2 68.664.1
c,d
VIB 68.362.8 72.763.9
SHAM 71.965.5 74.563.0
c
Significant between-group differences (p,0.05) for change between baseline
and 21 d, determined by simple effect tests with Bonferroni adjustments are
indicated by the following:
aGroup change is significantly different than treated
VIB leg;
bGroup change is significantly different than treated SHAM leg;
cGroup
change is significantly different than untreated VIB leg;
d Group change is
significantly different than untreated SHAM leg. Values are the unadjusted
mean 6 SD (n=8 for BTX-SHAM and VIB; n=9 for BTX-VIB; n=11 for SHAM).
doi:10.1371/journal.pone.0036486.t001
Table 2. Effect of treatment (BTX-VIB, BTX-SHAM, VIB, SHAM)
on individual muscle masses (mg) 21 days following
treatment.
Posterior Anterior
Leg Treatment Gastrocnemius Soleus Tibialis Anterior
Treated BTX-VIB 29.764.7
a,b 3.760.6
a,b 27.462.7
a,b,c
BTX-
SHAM
34.069.7
a,b 3.960.7
a,b 20.867.4
a,b
VIB 101.366.8 6.860.8 41.661.8
SHAM 100.365.4 6.361.1 41.165.1
Untreated BTX-
VIB
89.665.0
d 7.060.5 36.662.4
BTX-
SHAM
92.565.8
d 6.460.6 36.362.7
VIB 102.264.0 6.760.8 38.661.7
SHAM 103.567.0 6.560.8 38.662.5
Significant Group x Leg interaction for muscle mass (p,0.001, partial g
2=0.81
to 0.96). Significantly lower muscle masses (p,0.05) determined by simple
effect tests with Bonferroni adjustments are indicated by the following:
a compared with untreated leg;
b compared with SHAM and VIB treated legs
(partial g
2=0.93 to 0.99);
c compared with BTX-SHAM treated leg (partial
g
2=0.30);
d compared with SHAM and VIB untreated leg (partial g
2=0.95 to
0.97). Values are the mean 6 SD (n=8 for BTX-SHAM and VIB; n=9 for BTX-VIB;
n=11 for SHAM).
doi:10.1371/journal.pone.0036486.t002
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PLoS ONE | www.plosone.org 5 May 2012 | Volume 7 | Issue 5 | e36486Figure 4. Effect of treatment on bone micro-architecture in the proximal tibial metaphysis on the treated (left) hindlimb. Significant
Group x Leg interactions for change between baseline and 21 d for BV/TV (p,0.001, partial g
2=0.51), and TbTh (p,0.001, partial g
2=0.64).
Significant between-group differences (p,0.05) determined by simple effect tests with Bonferroni adjustments are indicated by the following:
a BTX-
VIB , SHAM;
b BTX-SHAM , SHAM;
c BTX-VIB , VIB;
d BTX-SHAM , VIB. Values are the unadjusted mean 6 SE (n=8 for BTX-SHAM and SHAM; n=9
for BTX-VIB, n=11 for VIB).
doi:10.1371/journal.pone.0036486.g004
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PLoS ONE | www.plosone.org 6 May 2012 | Volume 7 | Issue 5 | e36486Figure 5. Effect of treatment on bone micro-architecture in the proximal tibial epiphysis of the treated (left) hindlimb. Significant
Group x Leg interactions for change between baseline and 21d for BV/TV (p,0.001, partial g
2=0.42), TbTh (p,0.001, partial g
2=0.34) and DA
(p,0.001, partial g
2=0.46). Significant between-group differences (p,0.05) determined by simple effect tests with Bonferroni adjustments are
indicated by the following:
a BTX-VIB , SHAM;
b BTX-SHAM , SHAM;
c BTX-VIB , VIB;
d BTX-SHAM , VIB. Values are the unadjusted mean 6 SE (n=8
for BTX-SHAM and SHAM; n=9 for BTX-VIB, n=11 for VIB).
doi:10.1371/journal.pone.0036486.g005
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any micro-architectural parameters between the treated leg of the
BTX-VIB and BTX-SHAM groups, nor VIB and SHAM groups
in the tibia metaphysis (partial g
2,0.01) or epiphysis (partial
g
2,0.02).
The within-group change in cortical bone architecture was
significantly different in the treated leg of the BTX groups than the
SHAM group (Figure 6). Metaphyseal Ct.Ar declined 8.163.5%
and 5.562.5% in the BTX-VIB and BTX-SHAM groups,
respectively, but increased 12.061.5% in the SHAM group and
12.962.1% in the VIB group and these within-group decreases in
the BTX groups were significantly different from the SHAM
(p,0.001, partial g
2=0.8) and VIB groups (p,0.001, partial
g
2=0.09 to 0.18, Figure 6A). The decline in metaphyseal Ct.Ar
occurred primarily as a result of a significant increase in Ma.Ar in
the BTX groups (data not shown, p,0.001, partial g
2=0.53 for
Group x Leg interaction, p,0.002 for all significant comparisons,
partial g
2=0.16 to 0.51). The 1.962.6% and 3.762.8% decrease
in diaphyseal Ct.Ar in the BTX-VIB and BTX-SHAM groups,
respectively, was significantly different from the within-group
changes in the SHAM and VIB groups (p,0.001 for all significant
comparisons, partial g
2=0.39 to 0.43, Figure 6B). There were no
significant differences in change in cortical area between the
treated leg of the BTX-VIB and BTX-SHAM groups (partial
g
2=0.003 to 0.024), nor VIB and SHAM (partial g
2=0.39 to
0.71) groups.
There were no visible double labels in three samples examined
(n=1 from BTX-SHAM, n=2 from SHAM), and thus they were
excluded from the analysis. Processing errors led to exclusion of
four additional samples (n=1 from each group). Significant
ANOVAs (p,0.05, partial g
2=0.36 to 0.40) and Tukey’s post-
hoc tests indicated that BTX+VIB had significantly lower %dLS
(p=0.04, partial g
2=0.09), MS/BS (p=0.04, partial g
2=0.27),
and BFR/BS (p=0.04, partial g
2=0.22) than VIB, and
significantly lower %dLS (p=0.01, partial g
2=0.70) and BFR/
BS (p=0.01, partial g
2=0.74) than SHAM (Table 3). There were
no differences in any histomorphometric indices between the
BTX-VIB and BTX-SHAM groups (partial g
2=0.002 to 0.091),
nor VIB and SHAM groups (partial g
2=0.77 to 0.96).
Discussion
In this study, we found that 20 minutes of daily exposure to
high-frequency, low-magnitude vibration did not prevent muscle
and bone loss associated with BTX injection in BALB mice.
Further, we were unable to identify an anabolic effect of vibration
in either the presence or absence of muscle activity. Our results do
not lend support to the hypothesis that high-frequency, low-
magnitude vibration mimics the effects of postural muscle activity
on bone.
There are several possible explanations for our finding that
vibration did not prevent or attenuate BTX-induced bone loss.
Similartoourresult,Brouwerset al.[15]foundthatWBVappliedat
90 Hz, 0.3 g, for two 20 minute sessions/day for 6 weeks could not
attenuate bone loss in rats after ovariectomy. In contrast, previous
studies by Garman et al. found that neither muscle activity nor
Figure 6. Effect of treatment on Ct.Ar in the proximal tibial metaphysis (A) and diaphysis (B) of the treated (left) hindlimb. Significant
Group x Leg interactions for change between baseline and 21 d for metaphysis Ct.Ar (p,0.001, partial g
2=0.72), diaphysis Ct.Ar (p=0.10, partial
g
2=0.30). Significant between-group differences (p,0.05) determined by simple effect tests with Bonferroni adjustments are indicated by the
following:
a BTX-VIB , SHAM;
b BTX-SHAM , SHAM;
c BTX-VIB , VIB;
d BTX-SHAM , VIB. Values are the unadjusted mean 6 SE (n=8 for BTX-SHAM
and SHAM; n=9 for BTX-VIB, n=11 for VIB).
doi:10.1371/journal.pone.0036486.g006
Table 3. Effect of treatment on static and dynamic
histomorphometric indices in the trabecular region of the
proximal tibia metaphysis in the treated leg.
Treatment sLS/BS dLS/BS MS/BS MAR BFR/BS
(%) (%) (%) (mm/d)
(mm
3/mm
2/
y)
BTX-VIB 19.4615.2 5.664.4
a 15.369.2
a 1.3360.25
70.2635.7
a,b
BTX-SHAM 15.462.4 7.464.8
b 15.164.8 1.3260.17 73.2625.0
VIB 28.1611.2 16.269.7 30.3614.5 1.3260.28 150.6683.0
SHAM 20.765.9 17.868.4 28.268.7 1.4960.21 152.0650.7
aGroup is significantly lower than treated VIB leg (p,0.05);
b Group is
significantly lower than treated SHAM leg (p,0.01). Values are the mean 6 SD
(n=8 for BTX-VIB and SHAM; n=6 for BTX; n=7 for VIB). Four samples were
excluded due to processing errors. Samples (n=3) without double labels were
also excluded. sLS/BS = % single-labelled surface; dLS/BS = % double labelled
surface; MS/BS = % mineralizing surface; MAR = mineral apposition rate; BFR/
BS = bone formation rate, normalized by bone surface.
doi:10.1371/journal.pone.0036486.t003
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formation in animals undergoing normal loading [21] or hindlimb
unloading [22] during the other hours of the day. The primary
difference between the Garman et al. [22] study and the current
study was the use of BTX rather than hindlimb unloading to trigger
disuse to specifically test the hypothesis that vibration mimics the
effects of muscle activity on bone. However, there were several
similarities between the studies. In both studies, voluntary muscle
activity was absent during vibration loading because the animals
were under anaesthesia. Further, the magnitude of bone loss (or
attenuation of bone gain) appeared to be similar following 3 weeks
disuse due to hindlimb unloading (,49% of control value) or BTX
(,61% of control value after BTX). However, there are differences
in daily muscle activity in animals subjected to hindlimb unloading
compared with BTX injection. For example, soleus electromyo-
graphical (EMG) activity appears to recover more rapidly after
hindlimb unloading than BTX injection [39,40]. Further, EMG
activity in tibialis anterior increased during hindlimb unloading
[39], whereas considerable atrophy was noted after BTX injection
compared withothermeans ofachieving disuse[27]. Wepreviously
found that weight-bearing ability in the BTX-injected limb was not
eliminated and began to recover 2–3 week post-injection [29].
Thus, because of the difference in daily mechanical stimulus in
hindlimb-unloaded and BTX-injected limbs, the combined results
of these two studies suggest that the role of muscle activity in
transmitting vibration is unclear.
Another possible explanation for the absence of a vibration
effect is that the vibration stimulus intensity (i.e., the combination
of duration, acceleration magnitude, and frequency) may have
been insufficient to replace the absence of muscle activity. We only
tested a single vibration protocol that we proposed was an
approximation of strain signals induced by postural muscle
activity, and did not characterize the strains induced by
endogenous postural muscle activity. It is possible that varying
one or more parameters would have produced a different result.
We measured slightly larger peak-to-peak strain magnitudes
(5.8 me vs. 2.2 me) for the same frequency and peak acceleration
as reported by Garman et al. [21,22]. However, bone formation
responses to low-magnitude stimuli do not appear to be strain-
regulated [11], and increasing acceleration magnitudes did not
correspond to increased bone formation [41]. Thus, it is unlikely
that the subtle difference in strain magnitude had a large effect on
our results. Further, postural muscle activity is normally active
throughout the day, and we attempted to replace it with only
20 minutes/day. Because we applied the vibration while the
mouse was under anaesthesia, it was not possible to apply the
stimulus throughout the whole day. However, vibration applied
for a long duration (12 hr/d) has been previously shown to
negatively alter bone mineralization patterns [42].
There are other factors, aside from strain magnitude, that may
be important factors to replace muscle activity with vibration.
High-frequency oscillations and/or electrical activity associated
with muscle activity are thought to maintain bone homeostasis
[3,17]. However, the highest frequencies for soft tissue oscillation
occur in the direction normal to the skin surface [43]. In contrast,
we applied the stimulus along the longitudinal axis of the bone.
Further, muscle oscillation frequency, recorded with acceler-
ometers [43] and vibromyograms [44], as well as motor unit firing
frequency [45] increase with muscle force production. During
daily activities, peak force production by postural muscles is
relatively constant regardless of the task (e.g., slow walking or fast
running) [46]. In contrast, higher force production occurs in
muscles with a high percentage of fast-twitch muscle fibres, for
more demanding activities such as fast running or jumping. We
would, therefore, expect postural muscle oscillations to occur with
lower forces with frequency content at the lower end of the
frequency spectrum, and that high-frequency oscillations would
occur less often. Thus, to accurately mimic postural muscle activity
in future studies, stimuli should be applied normal to bone’s
longitudinal axis at a lower frequency (e.g., 15 Hz).
In addition to the inability to replace muscle activity with
vibration, BTX may also have induced an overwhelming
osteoclastic response that could not be overcome by the small
magnitude vibrations. Most animal studies that observed a positive
response to vibration detected small, but significant differences in
dynamic histomorphometry, indicating anabolic effects of vibra-
tion [7,8,9,21,22]. In contrast, the results supporting an anti-
catabolic effect of vibration are mixed. In separate studies by Xie
et al. a similar vibration protocol was noted to have a positive
effect [8] and a lack of effect on osteoclastic activity [9]. Further,
gene expression patterns in response to vibration are complex as
genes associated with both bone formation and resorption were
significantly up-regulated [47]. Thus, it is possible that vibration
and BTX influence bone remodelling through different, but non-
antagonistic signalling pathways.
There is evidence to suggest that both BTX and vibration
influence bone through the RANK ligand pathway. RANK ligand
(receptor activator of nuclear factor kb ligand, RANKL) is an
osteoclastic differentiation factor that binds to its receptor RANK
on the surface of osteoclasts and osteoclast precursor cells [48].
Binding of RANKL to RANK triggers osteoclast formation,
fusion, activation, and survival [49]. BTX-induced bone loss likely
results from RANKL-mediated osteoclastic activation, as
a RANKL inhibitor was able to prevent BTX-induced bone loss
[50]. High-frequency, low-magnitude vibration has been shown to
suppress soluble RANKL release and RANKL mRNA expression
in osteocyte-like cells [51]. However, the upstream regulators of
RANKL release could be different in BTX and vibration, or the
delay (4 days) between BTX injection and initiation of the
vibration protocol may have been too long to prevent RANKL-
mediated osteoclastic activation.
To determine whether our vibration parameters were anabolic,
we also evaluated the effects of vibration in normal, healthy BALB
mice. We did not observe any osteogenic effects of vibration. One
of the few studies to demonstrate an anabolic effect of vibration in
healthy, skeletally mature mice used the C57BL/6 mice which are
known to be more sensitive to mechanical loading [10,52]. In
contrast, Christiansen et al. [14] found that vibration applied
without weight-bearing to C57BL/6 mice at 70 or 140 Hz, 0.5 g
for 15 minutes/day for 5 weeks was at best weakly anabolic for
trabecular bone. Further, in general, BALB mice tend to be less
responsive to mechanical stimuli [10] and thus it is possible that
the strain of mice used in this study were simply not responsive
when healthy. The contrasting results from various studies
highlight that vibration effects appear to be species-, protocol-
and site-specific [10,11,14,15,21]. For example, when high-
frequency, low-magnitude has been applied to cohorts of post-
menopausal women, studies have found increased hip aBMD [53],
increased hip aBMD in women who complied with the vibration
prescription only [13], and no effect [54]. When combined with
resistance training, studies have shown no additional effect of
vibration on lumbar or hip aBMD [55,56]. The variability in
results, as well as the lack of understanding of the mechanism
underpinning bones’ response to vibration makes it difficult to
design appropriate interventions to prevent bone loss in post-
menopausal women.
The absence of an effect of low-magnitude vibration on muscle
mass and cross-sectional area was expected as muscle stimulation
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effect of BTX on normal [57] and spastic muscle [58,59]. Further,
enhanced muscle strength or power has typically been reported
following stimulation with high-intensity vibration, greater than 1
g acceleration [53,60,61].
In addition to the limitations already described, our conclusions
are based on several assumptions. To begin, we assumed that any
bone loss that occurred following BTX injection was a result of
BTX-induced muscle atrophy. We believe this was a valid
assumption as we previously showed that BTX-induced bone loss
could be explained by declines in muscle cross-sectional area and
that any effect of BTX on bone, independent of its effect on
muscle, were likely small or negligible [27]. In addition, mice
injected with BTX experienced significant loss of body mass, but
the relative loss was similar to what we reported previously [25],
despite the addition of daily anaesthesia in the current study.
Further, we may have found enhanced bone formation with
a longer study duration [8,9]. However, based on our previous
findings, we anticipated the recovery of weight-bearing to begin 2–
3 weeks post-injection in BTX-injected animals, and recovery of
MCSA to begin 4–6 weeks post-injection. Thus, lengthier
application of the stimulus without additional BTX injection
would have hindered our ability to apply vibration in the absence
of muscle activity.
In conclusion, our data do not support the hypothesis that high-
frequency, low-magnitude vibration promotes bone adaptation by
mimicking postural muscle activity. In terms of the molecular and
cellular mechanisms driving bone formation, recent studies
suggested that acceleration of the osteocyte or osteoblast nucleus,
rather than matrix strains [21,62], may trigger the release of
osteogenic factors. Further, vibration may promote an osteogenic
response by stimulating proliferation and differentiation of
mesenchymal stem cells [63,64,65]. However, the nature of the
endogenous mechanical signal that stimulates these signalling
pathways is not yet understood. Given the discrepancy in finding
positive effects of vibration between various studies, continued
investigation of this mechanism is required to better understand
which parameters should be chosen to maximize the therapeutic
effect of vibration in humans.
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